• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Four New Markers in Early RA Diagnosis

Article

UH-RA1, UH-RA9, UH-RA14, and UH-RA21 have been identified as four new biomarkers that can help in early diagnosis of rheumatoid arthritis (RA), specifically in one-third of patients who test negative for currently recognized antibodies. MedPage Today reports:

Four new biomarkers have been identified that can help in the early diagnosis of rheumatoid arthritis (RA), particularly among the one-third of patients who test negative for currently recognized autoantibodies, a researcher reported here.

In a cohort of 292 patients, the diagnosis of RA couldn't be confirmed in 34% because tests for rheumatoid factor (RF) and anti-cyclic citrullinated peptides (CCP) were negative, said Liesbeth M. De Winter, who is a PhD student at Hasselt University in Diepenbeek, Belgium.

But that number fell to 24% using a test panel that included the biomarkers UH-RA1, UH-RA9, UH-RA14, and UH-RA21, De Winter explained at the annual meeting of the European League Against Rheumatism (EULAR).

Read the full story here: http://bit.ly/1axh5qn

Related Videos
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Ryan Stice, PharmD
Raajit Rampal, MD, PhD, screenshot
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.